These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 17541126

  • 21. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A, Kunz M, Moschovitis A, Nageh T, Schwerzmann M, Seiler C, Mattle HP, Windecker S, Meier B.
    Heart; 2008 Mar; 94(3):336-41. PubMed ID: 17639093
    [Abstract] [Full Text] [Related]

  • 22. Patent foramen ovale closure: a new therapy for migraine.
    Schwerzmann M, Nedeltchev K, Meier B.
    Catheter Cardiovasc Interv; 2007 Feb 01; 69(2):277-84. PubMed ID: 17253601
    [Abstract] [Full Text] [Related]

  • 23. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons.
    Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL.
    Lancet; 2000 Nov 11; 356(9242):1648-51. PubMed ID: 11089825
    [Abstract] [Full Text] [Related]

  • 24. Patent foramen ovale: does it play a role in the pathophysiology of migraine headache?
    Beda RD, Gill EA.
    Cardiol Clin; 2005 Feb 11; 23(1):91-6. PubMed ID: 15676272
    [Abstract] [Full Text] [Related]

  • 25. [Percutaneous closure of patent foramen ovale: a wise approach].
    Gaspardone A, Iani C, Papa M.
    G Ital Cardiol (Rome); 2008 Sep 11; 9(9):593-602. PubMed ID: 18783080
    [Abstract] [Full Text] [Related]

  • 26. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
    Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici M, Mattle HP, Rothwell PM, PERFORM Study Investigators.
    Cerebrovasc Dis; 2009 Sep 11; 27(6):608-13. PubMed ID: 19407444
    [Abstract] [Full Text] [Related]

  • 27. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP, Cammalleri V, Mulè M, Scarabelli M, Barbanti M, Scardaci F, Mangiafico S, Immè S, Capodanno D, Tamburino C.
    Catheter Cardiovasc Interv; 2009 Oct 01; 74(4):607-14. PubMed ID: 19360875
    [Abstract] [Full Text] [Related]

  • 28. [Migraine as predictive factor of the presence of atrial septum aneurysm in patients with stroke and patent foramen ovale].
    Martín Balbuena S, Fuentes B, Lara M, Ortega-Casarrubios MA, Martínez P, Díez-Tejedor E.
    Neurologia; 2009 Apr 01; 24(3):160-4. PubMed ID: 19418291
    [Abstract] [Full Text] [Related]

  • 29. Interatrial shunt closure devices in patients with nickel allergy.
    Reddy BT, Patel JB, Powell DL, Michaels AD.
    Catheter Cardiovasc Interv; 2009 Oct 01; 74(4):647-51. PubMed ID: 19777603
    [Abstract] [Full Text] [Related]

  • 30. Migraine is associated with menorrhagia and endometriosis.
    Tietjen GE, Conway A, Utley C, Gunning WT, Herial NA.
    Headache; 2006 Mar 01; 46(3):422-8. PubMed ID: 16618258
    [Abstract] [Full Text] [Related]

  • 31. Maximal potential patent foramen diameter does not correlate with the type or frequency of the neurologic event prior to closure.
    Kutty S, Brown K, Qureshi AM, Latson LA.
    Cardiology; 2009 Mar 01; 113(2):111-5. PubMed ID: 19023203
    [Abstract] [Full Text] [Related]

  • 32. Frequency of migraine attacks following stroke starts to decrease before PFO closure.
    Lapergue B, Rosso C, Hadrane L, Labreuche J, Abboud H, Brochet E, Juliard JM, Amarenco P.
    Neurology; 2006 Sep 26; 67(6):1099-100. PubMed ID: 17000993
    [No Abstract] [Full Text] [Related]

  • 33. [A survey on cerebral infarction/transient ischemic attack inpatients compliance with secondary stroke prevention and follow-up 90 days].
    Ma RH, Wang YJ, Wang CX, Zhao XQ, Wang YL, Xu MJ, Wei M, Li Y, Zhang Z, Zhang WW, Wang L, Lin L, Li HT, Zheng T, Wang XW, Li JJ, Lü Y, Qi D.
    Zhonghua Yi Xue Za Zhi; 2008 Oct 14; 88(37):2618-22. PubMed ID: 19080709
    [Abstract] [Full Text] [Related]

  • 34. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
    De Bruin ML, Dorresteijn LD, van't Veer MB, Krol AD, van der Pal HJ, Kappelle AC, Boogerd W, Aleman BM, van Leeuwen FE.
    J Natl Cancer Inst; 2009 Jul 01; 101(13):928-37. PubMed ID: 19535773
    [Abstract] [Full Text] [Related]

  • 35. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts.
    Rigatelli G, Giordan M, Braggion G, Aggio S, Chinaglia M, Zattoni L, Milan T, Cardaioli P.
    Cardiovasc Revasc Med; 2007 Jul 01; 8(4):248-50. PubMed ID: 18053946
    [Abstract] [Full Text] [Related]

  • 36. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 01; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 37. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months.
    Rahiman A, Saver JL, Porter V, Buxton W, McNair N, Razinia T, Ovbiagele B.
    J Stroke Cerebrovasc Dis; 2008 Feb 01; 17(1):5-8. PubMed ID: 18190814
    [Abstract] [Full Text] [Related]

  • 38. Outcome of carotid artery stenting for primary versus restenotic lesions.
    Cuadra S, Hobson RW, Lal BK, Goldstein J, Chakhtoura E, Jamil Z.
    Ann Vasc Surg; 2009 Feb 01; 23(3):330-4. PubMed ID: 18692988
    [Abstract] [Full Text] [Related]

  • 39. [Migraine, stroke and patent foramen ovale--connected or not?].
    Vuković V, Aleksić-Shihabi A, Lovrencić-Huzjan A, Demarin V.
    Acta Med Croatica; 2008 May 01; 62(2):197-203. PubMed ID: 18710084
    [Abstract] [Full Text] [Related]

  • 40. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
    Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D, AEGIS Investigator Study Group.
    Headache; 2008 Mar 01; 48(3):341-54. PubMed ID: 18302700
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.